STAT+: Cytokinetics heart drug wins FDA approval, the bio...
It took 27 years, but Cytokinetics secured its first U. S.
What’s Happening
Not gonna lie, It took 27 years, but Cytokinetics secured its first U.
Biotech Biotech STAT Plus: White House unveils largest batch of drug pricing agreements yet By Daniel Payne and John Wilkerson Biotech Biotech STAT Plus: BioMarin CEO says $4. 8 billion Amicus deal will lead to cost savings and revenue growth By Matthew Herper The Readout The Readout STAT Plus: Former Pfizer R&D chief not so optimistic about biopharma now By Meghana Keshavan Biotech Biotech STAT Plus: BioMarin to buy Amicus Therapeutics for $4. (yes, really)
8B, bringing together rare disease biotechs By Jason Mast Opinions+ Opinions+ STAT Plus: I’m the former head of Pfizer R&D.
Why This Matters
I’m worried about biopharma’s future By John L. LaMattina STAT Plus: Data on Humana’s clinics looked dismal.
Medical professionals are taking note of this development.
The Bottom Line
This story is still developing, and we’ll keep you updated as more info drops.
Are you here for this or nah?
Daily briefing
Get the next useful briefing
If this story was worth your time, the next one should be too. Get the daily briefing in one clean email.
Reader reaction
